Opmed
Opmed sells an AI platform for hospital operations and scheduling, built first for the operating room. Its Forecast layer predicts case duration and procedure length, turnover time, block utilization, PACU and admission length of stay, demand and staffing needs; Allocate plans block allocation, shift assignment and staff to patient matching across rooms, staff and equipment; and Adjust responds to no shows, late cancellations, add ons, urgent cases, equipment maintenance and operational emergencies with updated schedules and recommended next steps. A custom workflow layer reads each site's rules, exceptions and live changes, surfaces recommendations for teams to review and approve, and learns from approvals and overrides.
Surgical services, procedural services such as cardiovascular labs, and rehabilitation scheduling are the three care areas. Geisinger and AtlantiCare run it in perioperative services, Opmed and Mayo Clinic have presented its cardiovascular procedure scheduling work, and Raphael Hospital and Herzliya Medical Center in Israel are named users. Opmed AI, Inc. raised a $15 million Series A; Dr. Mor Brokman Meltzer is chief executive, Avi Paz chief technology officer and Prof. Baruch Barzel chief scientist.
Capability Axes
An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read
Prediction and optimization run the core modules. Duration models forecast case and procedure length, turnover, PACU stay and demand from each site's history, and Opmed says they cut duration prediction error roughly in half against clinician estimates; the Live Schedule Optimizer and Block Optimizer then align cases, rooms, staff and equipment and model block reallocation, and agentic workflows turn live changes into recommended next steps.
Around those models sit dashboards for performance and throughput, rule configuration and EHR connected scheduling workflows that carry value of their own.
People approve what the platform recommends. Opmed reads schedules, resources, rules, exceptions and live operational changes, then surfaces the next best action for teams to review, approve and act on, and it captures approvals, overrides and outcomes to improve later recommendations. Teams configure the rules, priorities and exception handling the workflows follow.
Which actions, if any, the agents carry out without an approval is not stated.
The platform is described as AI native, combining duration prediction, schedule and block optimization and agentic workflows, with recommendation logic built on each site's mapped workflows and configured rules. Its chief scientist, Prof. Baruch Barzel, and a director of AI lead the technical work.
Model types, training data and accuracy figures beyond the comparison with clinician estimates are not published.
Opmed presents duration prediction, optimization and the agentic workflow layer as its own platform, and its team includes a chief scientist and a director of AI. Recommendation logic is built on each customer's mapped workflows and configured rules, and approvals and overrides feed back into later recommendations.
No hosting provider, outside model or subprocessor is named.
Results are reported by care area. In surgery Opmed cites a 10 percent increase in OR utilization, 20 percent less nurse overtime and $1.2 million recovered per OR each year; in procedural services, duration prediction error about half that of clinician estimates, more than 200 OR hours saved per room each year and 67 percent fewer delays and cancellations; in rehabilitation, a 95 percent reimbursement approval rate, 12 percent more billable hours and 29 percent better provider utilization. Geisinger and AtlantiCare are named deployments, and Opmed and Mayo Clinic have presented its cardiovascular scheduling work.
The figures come without a named site, period or method.
The platform reads schedules, case data and staffing from hospital systems through EHR connected workflows, which brings patient identifiers and procedure details into scheduling decisions. The public privacy policy covers the website, which is directed to healthcare professionals in the United States and Israel, and describes HTTPS and encryption for site data.
How product data is retained, whether it trains models across customers and how it is protected are not described.
Scheduling workflows connect to the EHR and handle case and patient level schedule data for hospital customers in the United States and Israel, including US systems such as Geisinger and AtlantiCare. The public terms and privacy policy cover the website and are governed by New York law.
No HIPAA statement or business associate agreement appears on the public pages.
Security information on the public site is limited to the website privacy policy, which mentions HTTPS and encryption and says no measure provides absolute security. The platform runs inside customer scheduling workflows connected to the EHR at systems such as Geisinger and AtlantiCare, across surgical, procedural and rehabilitation scheduling.
No certification, audit report or trust center is published.
The platform forecasts and allocates operating room time, procedure rooms, staff, equipment and therapist schedules. It makes no diagnostic or treatment recommendation for an individual patient, and its rehabilitation scheduling is aimed at compliance and reimbursement rather than clinical care.
Opmed makes no regulatory claim, and no FDA device listing exists for it.
Recommendations learn from each site's own decisions: approvals, overrides and outcomes feed later recommendations, and block allocation is modeled from historical utilization. That history can carry forward who has held operating room time and how cases have been sequenced.
No governance process, monitoring practice or fairness review of allocation across services or surgeons is published.
Recommendations wait for a person. Teams review, approve and act on the next best action the platform surfaces, overrides are captured, and schedule changes run through the hospital's own workflows, so a wrong forecast can be set aside before it moves a case.
The website terms disclaim warranties of accuracy, and no product warranty, service level or remediation commitment is published.
Opmed describes EHR connected workflows that bring live schedule optimization, AI recommendations, block planning and throughput insights into one operational layer, reading schedules, resources and live operational changes. Customers such as Geisinger and AtlantiCare run it alongside their record systems.
No EHR vendor, interface standard or write back path is named.
Delivery is a platform connected to each health system's EHR and scheduling workflows, with the forecasting, allocation and adjustment layers configured around local rules. Each deployment starts with workflow mapping and rule configuration for the site's rooms, staff and resources. Customers are named in the United States and Israel, and the company is Opmed AI, Inc.
Hosting, regions and tenancy are not stated.
Health systems buy through a demo and sales conversation, organized by care area and by the Forecast, Allocate and Adjust modules, with custom AI workflows built around each site's rules. The value case is set per operating room: $1.2 million recovered per OR each year, a 10 percent rise in OR utilization and 20 percent less nurse overtime, and in rehabilitation a 12 percent increase in billable hours.
Opmed publishes no price, unit of charge or contract term.
Three care areas are named. Surgical services cover OR scheduling, blocks, staffing and capacity; procedural services cover quick diagnostics through complex interventions, with imaging and specialized equipment allocation and cardiovascular procedure scheduling presented with Mayo Clinic; rehabilitation covers therapist and patient scheduling, with Three Birds One Mission as a named user. Geisinger and AtlantiCare are named in the US, and Raphael Hospital and Herzliya Medical Center in Israel.
Results are reported by care area rather than by named site.
Compared With
Each comparison carries a written verdict, the buyer conditions that favor each vendor, and a graded side by side. Pairs that cross a category boundary are grouped separately, and their verdicts state where the boundary sits rather than manufacturing a head to head.
Pricing
Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.
| Entry Price | Pricing Basis | BAA Tier | Implementation | Source |
|---|---|---|---|---|
|
Not published
|
Enterprise contracts through a demo and sales conversation, organized by care area and module. Rates are set in each contract and not published. | No business associate agreement or HIPAA statement is published. | Not published. Deployment includes workflow mapping and rule configuration for each site. | Vendor Published |
Opmed frames value per operating room, $1.2 million recovered per OR each year with a 10 percent rise in OR utilization and 20 percent less nurse overtime, and in rehabilitation a 12 percent increase in billable hours and a 95 percent reimbursement approval rate. It raised a $15 million Series A. Opmed publishes no rate card.